
CASTLE BIOSCIENCES INC — Investor Relations & Filings
Castle Biosciences Inc. is a diagnostics company that develops and commercializes innovative tests to guide patient care and improve health outcomes. The company focuses on translating a patient's unique tumor biology, particularly through gene expression profiling, into clinically actionable prognostic and diagnostic information. Its primary portfolio includes tests for dermatologic cancers, such as cutaneous melanoma and squamous cell carcinoma. These molecular tests are designed to provide healthcare providers with critical data to inform personalized disease management and treatment strategies. The clinical validity and utility of Castle Biosciences' tests are supported by an extensive body of peer-reviewed publications.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-29 | English | |
| 8-K - CASTLE BIOSCIENCES INC (0001447362) (Filer) | 2026-05-06 | English | |
| ARS - CASTLE BIOSCIENCES INC (0001447362) (Filer) | 2026-04-08 | English | |
| DEF 14A - CASTLE BIOSCIENCES INC (0001447362) (Filer) | 2026-04-08 | English | |
| 144 - CASTLE BIOSCIENCES INC (0001447362) (Subject) | 2026-03-26 | English | |
| 10-K - CASTLE BIOSCIENCES INC (0001447362) (Filer) | 2026-02-26 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47894306 | 8-K | 2026-05-29 | English | ||
| 42006662 | 8-K - CASTLE BIOSCIENCES INC (0001447362) (Filer) | 2026-05-06 | English | ||
| 33822403 | ARS - CASTLE BIOSCIENCES INC (0001447362) (Filer) | 2026-04-08 | English | ||
| 33821999 | DEF 14A - CASTLE BIOSCIENCES INC (0001447362) (Filer) | 2026-04-08 | English | ||
| 33052626 | 144 - CASTLE BIOSCIENCES INC (0001447362) (Subject) | 2026-03-26 | English | ||
| 32892042 | 10-K - CASTLE BIOSCIENCES INC (0001447362) (Filer) | 2026-02-26 | English | ||
| 32892041 | 8-K - CASTLE BIOSCIENCES INC (0001447362) (Filer) | 2026-02-26 | English | ||
| 29859414 | SCHEDULE 13G Filing | 2026-02-17 | English | ||
| 32892040 | 4 - CASTLE BIOSCIENCES INC (0001447362) (Filer) | 2026-02-05 | English | ||
| 29859421 | 4 Filing | 2026-01-22 | English | ||
| 29859432 | 4 Filing | 2026-01-14 | English | ||
| 29859428 | 4 Filing | 2026-01-14 | English | ||
| 29859417 | 4 Filing | 2026-01-14 | English | ||
| 29859415 | 4 Filing | 2026-01-14 | English | ||
| 29859434 | 8-K Filing | 2026-01-13 | English | ||
Market data
Market data not available
Price history
Peer group · Other human health activities n.e.c
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Fangzhou Inc.
Leading online platform specializing in chronic disease man…
|
6086 | KY | Human health and social work ac… |
|
FLEURY SA
Provides diagnostic medicine, clinical analysis, and integr…
|
— | BR | Human health and social work ac… |
|
Fulgent Genetics, Inc.
Provides comprehensive genetic testing solutions using NGS …
|
FLGT | US | Human health and social work ac… |
|
Fureasu Co.,Ltd.
Provides comprehensive in-home healthcare, including massag…
|
7062 | JP | Human health and social work ac… |
|
GC Genome Corporation
A clinical diagnostics company specializing in genomic anal…
|
340450 | KR | Human health and social work ac… |
|
Gemoscan Canada, Inc.
Detects food sensitivities via simple blood tests to provid…
|
— | CA | Human health and social work ac… |
|
GeneDx Holdings Corp.
A genomics company providing genetic testing for rare and p…
|
WGS | US | Human health and social work ac… |
|
GENETIC TECHNOLOGIES LIMITED
Develops predictive genetic risk assessment tools for chron…
|
GTG | AU | Human health and social work ac… |
|
Gian Life Care Limited
Provides diagnostic, pathology, and radiology services and …
|
542918 | IN | Human health and social work ac… |
|
GSH CORP PARTICIPAÇÕES S.A.
Specialized provider of clinical hemotherapy and nuclear me…
|
— | BR | Human health and social work ac… |
CASTLE BIOSCIENCES INC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32601/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32601 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32601 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32601 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32601}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CASTLE BIOSCIENCES INC (id: 32601)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.